Browse > Article
http://dx.doi.org/10.14456/apjcp.2016.65/APJCP.2016.17.7.3131

E1/E2 of Hepatitis C Virus Genotype-4 and Apoptosis  

Zekri, Abdel-Rahman N (Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University)
Sobhy, Esraa (Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University)
Hussein, Nehal (Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University)
Ahmed, Ola S (Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University)
Hussein, Amira (Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University)
Shoman, Sahar (Faculty of Science, Microbiology Department, Ain Shams University)
Soliman, Amira H (Department of Clinical Pathology, National Cancer Institute, Cairo University)
El-Din, Hanaa M Alam (Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.17, no.7, 2016 , pp. 3131-3138 More about this Journal
Abstract
Several studies have addressed the possible role of hepatitis C virus genotype-4 (HCV GT4) in apoptosis. However, this still not fully understood. In the current study a re-constructed clone of E1/E2 polyprotein region of the HCV GT4 was transfected into the Huh7 cell line and a human apoptotic PCR array of 84 genes was used to investigate its possible significance for apoptosis. Out of the 84 genes, only 35 showed significant differential expression, 12 genes being up-regulated and 23 down-regulated. The highest-up regulated genes were APAF1 (apoptotic peptidase-activating factor 1), BID (BH3 interacting domain death agonist) and BCL 10 (B-cell CLL/lymphoma protein 10) with fold regulation of 33.2, 30.1 and 18.9, respectively. The most down-regulated were FAS (TNF receptor super family), TNFRSF10B (tumor necrosis factor receptor super-family member 10b) and FADD (FAS-associated death domain) with fold regulation of -30.2, -27.7 and -14.9, respectively. These results suggest that the E1/E2 proteins may be involved in HCV-induced pathogenesis by modulating apoptosis through the induction of the intrinsic apoptosis pathway and disruption of the BCL2 gene family.
Keywords
HCV; genotype 4; apoptosis; caspase; intrinsic pathway; BCL2;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Tanase C, Albulescu R, Codrici E, et al (2015). Decreased expression of APAF-1 and increased expression of cathepsin B in invasive pituitary adenoma. Onco Targets Ther, 8, 81-90.
2 Tawar R, Colpitts C, Timm J, et al (2015). Acute hepatitis C virus infection induces anti-host cell receptor antibodies with virus-neutralizing properties. Hepatol, 62, 726-36.   DOI
3 Tsujimoto Y (1998). Role of Bcl-2 family proteins in apoptosis: apoptosomes or mitochondria? Genes Cells, 3, 697-707.   DOI
4 Urbaczek A, Ribeiro L, Ximenes V, et al (2014). Inflammatory response of endothelial cells to hepatitis C virus recombinant envelope glycoprotein 2 protein exposure. Memorias do Inst Oswaldo Cruz, 109, 748-56.   DOI
5 Vogler M, Butterworth M, Majid A, et al (2009). Concurrent upregulation of BCL-XL and BCL2A1 induces approximately 1000-fold resistance to ABT-737 in chronic lymphocytic leukemia. Blood, 113.
6 Wu H, Che X, Zheng Q, et al (2014). Caspases: a molecular switch node in the crosstalk between autophagy and apoptosis. Int J Biochem Cell Biol, 10, 1072-83.
7 Yonezawa T, Kurata R, Kimura M, et al (2011). Which CIDE are you on? Apoptosis and energy metabolism. Mol Biosyst, 7, 91-100.   DOI
8 Yui D, Yoneda T, Oono K, et al (2001). Interchangeable binding of Bcl10 to TRAF2 and cIAPs regulates apoptosis signaling. Oncogene, 20, 4317-23.   DOI
9 Zekri A, Bahnassy A, Hafez M, et al (2011). Characterization of chronic HCV infection-induced apoptosis. s, 10, 4.   DOI
10 Zhang G, Wan Y, Zhang Y, et al (2015). Expression of Mitochondria-Associated Genes (PPARGC1A, NRF-1, BCL-2 and BAX) in follicular development and atresia of goat ovaries. Reprod Domest Anim, 50, 465-73.   DOI
11 Manara A, Lindsay J, Marchioretto M, et al (2009). Bid binding to negatively charged phospholipids may not be required for its pro-apoptotic activity in vivo. Biochim Biophys Act, 1791, 997-1010.   DOI
12 McIlwain D, Berger T, Mak T (2015). Caspase functions in cell death and disease. Cold Spring Harb Perspect Bioly, 7.
13 Miller F, Abu-Raddad L (2010). Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt. Proc Natl Acad Sci U S A, 107.
14 Moradpour D, Mullhaupt B. (2015). Hepatitis C: epidemiology natural course and diagnosis. Rev Medicale Suisse, 11, 896-901 (in French).
15 Okasha O, Munier A, Delarocque-Astagneau, et al (2015). Hepatitis C virus infection and risk factors in health-care workers at Ain Shams University Hospitals, Cairo, Egypt. East Mediterr Heal J = La Rev sante la Mediterranee Orient = al-Majallah al-sihhiyah li-sharq al-mutawassit, 21, 199-212.
16 Pavio N, Lai MMC (2003). The hepatitis C virus persistence: how to evade the immune system? J Biosci, 28, 287-304.   DOI
17 Revie D, Salahuddin S (2011). Human cell types important for hepatitis C virus replication in vivo and in vitro: old assertions and current evidence. Virol J, 8.
18 Skulachev V (1998). Cytochrome c in the apoptotic and antioxidant cascades. FEBS Lett, 423, 275-80.   DOI
19 Riad S, El-Ekiaby N, Mekky R, et al (2015). Expression signature of microRNA-155 in hepatitis C virus genotype 4 infection. Biomed reports, 3, 93-97.   DOI
20 Shalaeva D, Dibrova D, Galperin M, et al (2015). Modeling of interaction between cytochrome c and the WD domains of Apaf-1: bifurcated salt bridges underlying apoptosome assembly. Biol Direct, 10, 29.   DOI
21 Burlone M, Budkowska A (2009). Hepatitis C virus cell entry: role of lipoproteins and cellular receptors. J Gen Virol, 90, 1055-70.   DOI
22 Barathan M, Gopal K, Mohamed R, et al (2015). Chronic hepatitis C virus infection triggers spontaneous differential expression of biosignatures associated with T cell exhaustion and apoptosis signaling in peripheral blood mononucleocytes. Apoptosis, 20, 466-80.   DOI
23 Binder J, Tetangco S, Weinshank M, et al (2011). Development of hepatitis C virus chimeric replicons for identifying broad spectrum NS3 protease inhibitors. Antiviral Res, 91, 102-11.   DOI
24 Bouchardeau F, Cantaloube J, Chevaliez S, et al (2007). Improvement of hepatitis C virus (HCV) genotype determination with the new version of the INNO-LiPA HCV assay. J Clin Microbiol, 45.
25 Cerella C, Teiten M-H, Radogna F, et al (2014). From nature to bedside: pro-survival and cell death mechanisms as therapeutic targets in cancer treatment. Biotechnol Adv, 32.
26 Chaabane W, Cieslar-Pobuda A, El-Gazzah M, et al (2014). Human-gyrovirus-Apoptin triggers mitochondrial death pathway--Nur77 is required for apoptosis triggering. Neoplasia, 16, 679-93.   DOI
27 Chambers T, Fan X, Droll D, et al (2005). Quasispecies heterogeneity within the E1/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection. J Virol, 79, 3071-83.   DOI
28 Abd Elrazek A, Bilasy S, Elbanna, A, et al (2014). Prior to the oral therapy, what do we know about HCV-4 in Egypt: a randomized survey of prevalence and risks using data mining computed analysis. Medicine (Baltimore), 93.   DOI
29 Chiou H, Hsieh Y, Hsieh M, et al (2006). HCV E2 may induce apoptosis of Huh-7 cells via a mitochondrial-related caspase pathway. Biochem Biophys Res Commun, 345, 453-8.   DOI
30 Ciccaglione A, Marcantonio C, Tritarelli E, et al (2004). The transmembrane domain of hepatitis C virus E1 glycoprotein induces cell death. Virus Res, 104.
31 Abd El-Wahab E, Mikheal A, Sidkey F , et al (2014). Factors Associated with Hepatitis C Infection among Chronic HCV Egyptian Patients. Iran J Public Health, 43, 1510-8.
32 Ahmad M, Srinivasula S, Wang L, et al (1997). CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP. Cancer Res, 57, 615-9.
33 Bailey J, Wasilewski L, Snider A, et al (2015). Naturally selected hepatitis C virus polymorphisms confer broad neutralizing antibody resistance. J Clin Investigat, 125, 437-47.   DOI
34 Alibek K, Irving S, Sautbayeva Z, et al (2014). Disruption of Bcl-2 and Bcl-xL by viral proteins as a possible cause of cancer. Infect Agent Cancer, 9, 44.   DOI
35 Aweya J, Tan J (2011). Modulation of programmed cell death pathways by the hepatitis C virus. Front Biosci (Landmark Ed), 16, 608-18.   DOI
36 Bailey D, Kashyap M, Bouton L, et al (2006). Interleukin-10 induces apoptosis in developing mast cells and macrophages. J Leukoc Biol, 80, 581-9.   DOI
37 Bantel H, Lugering A, Poremba C, et al (2001). Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection. Hepatol, 34, 758-67.   DOI
38 Bantel H, Schulze-Osthoff K (2003). Apoptosis in hepatitis C virus infection. Cell Death Differ, 10, 48-58.   DOI
39 Kalkeri G, Khalap N, Akhter S, et al (2001). Hepatitis C viral proteins affect cell viability and membrane permeability. Exp Mol Pathol, 71, 194-208.   DOI
40 Jin X, Wu X-X, Jin C, et al (2012). Delineation of apoptotic genes for synergistic apoptosis of lexatumumab and anthracyclines in human renal cell carcinoma cells by polymerase chain reaction array. Anticancer Drugs, 23, 445-54.   DOI
41 Kamegaya Y, Hiasa Y, Zukerberg L, et al (2005). Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesis. Hepatol, 41, 660-7.   DOI
42 Lamkanfi M, Kanneganti T (2010). Caspase-7: a protease involved in apoptosis and inflammation. Int J Biochem Cell Biol, 42, 21-4.   DOI
43 Lee S, Kim Y, Kim C, et al (2005). E2 of hepatitis C virus inhibits apoptosis. J Immunol, 175.
44 Li G, Chang H, Zhai Y, et al (2013). Targeted silencing of inhibitors of apoptosis proteins with siRNAs: a potential anti-cancer strategy for hepatocellular carcinoma. Asian Pac J Cancer Prev, 14, 4943-52.
45 Ludwig-Galezowska A, Flanagan L, Rehm M (2011). Apoptosis repressor with caspase recruitment domain, a multifunctional modulator of cell death. J Cell Mol Med, 15.
46 Li J, Yuan J (2008). Caspases in apoptosis and beyond. Oncogene, 27.
47 Lim E, Chin R, Angus P, et al (2012). Enhanced apoptosis in post-liver transplant hepatitis C: effects of virus and immunosuppressants. World J Gastroenterol, 18.
48 Lin Y, Richburg J (2014). Characterization of the role of tumor necrosis factor apoptosis inducing ligand (TRAIL) in spermatogenesis through the evaluation of trail genedeficient mice. PloS One, 9.
49 Di Lorenzo C, Angus A, Patel A (2011). Hepatitis C virus evasion mechanisms from neutralizing antibodies. Viruses, 3, 2280-300.   DOI
50 Clausen L, Weis N, Ladelund S, et al (2015). Genetic variants in the apoptosis gene BCL2L1 improve response to interferonbased treatment of hepatitis C virus genotype 3 infection. Int J Mol Sci, 16, 3213-25.   DOI
51 Douam F, Lavillette D, Cosset F (2015). The mechanism of HCV entry into host cells. Prog Mol Biol Transl Sci, 129, 63-107.
52 Hildebrandt M, Roth J, Vaporciyan A, et al (2015). Genetic variation in the TNF/TRAF2/ASK1/p38 kinase signaling pathway as markers for postoperative pulmonary complications in lung cancer patients. Sci Rep, 5.
53 Figlerowicz M, Jackowiak P, Formanowicz P, et al(2010). Hepatitis C virus quasispecies in chronically infected children subjected to interferon-ribavirin therapy. Arch Virol, 155, 1977-87.   DOI
54 Fischer R, Baumert T, Blum H. (2007). Hepatitis C virus infection and apoptosis. World J Gastroenterol, 13, 4865-72.   DOI
55 Hase H, Kanno Y, Kojima H, et al (2002). CD27 and CD40 inhibit p53-independent mitochondrial pathways in apoptosis of B cells induced by B cell receptor ligation. J Biol Chem, 277, 46950-8.   DOI
56 Hussain S, Garantziotis S (2013). Interplay between apoptotic and autophagy pathways after exposure to cerium dioxide nanoparticles in human monocytes. Autophagy, 9.
57 Hussein N, Zekri A-RN, Abouelhoda, et al (2014). New insight into HCV E1/E2 region of genotype 4a. Virol J, 11.
58 Jang J, Kim S, Cho E, et al (2014). TRAIL enhances apoptosis of human hepatocellular carcinoma cells sensitized by hepatitis C virus infection: therapeutic implications. PloS One, 9.
59 Zhu L, Liu J, Xie Y, et al (2004). Expression of hepatitis C virus envelope protein 2 induces apoptosis in cultured mammalian cells. World J Gastroenterol, 10, 2972-8.   DOI